Xie C - Search Results

1

YHHU0895, a novel synthetic small-molecule microtubule-destabilizing agent, effectively overcomes P-glycoprotein-mediated tumor multidrug resistance.

Zhao H, Quan H, Xie C, Xu Y, Xie F, Hu Y, Lou L. Zhao H, et al. Among authors: xie f, xie c. Cancer Lett. 2012 Jan 1;314(1):54-62. doi: 10.1016/j.canlet.2011.09.013. Epub 2011 Sep 19. Cancer Lett. 2012. PMID: 21982683

2

Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.

Zhao H, Liu H, Chen Y, Xin X, Li J, Hou Y, Zhang Z, Zhang X, Xie C, Geng M, Ding J. Zhao H, et al. Among authors: xie c. Cancer Res. 2006 Sep 1;66(17):8779-87. doi: 10.1158/0008-5472.CAN-06-1382. Cancer Res. 2006. PMID: 16951194

3

Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo.

Zhang ZH, Chen Y, Zhao HJ, Xie CY, Ding J, Hou YT. Zhang ZH, et al. Cancer Biol Ther. 2007 Apr;6(4):587-95. doi: 10.4161/cbt.6.4.3888. Cancer Biol Ther. 2007. PMID: 17457040 Free article.

4

MFTZ-1, an actinomycetes subspecies derived antitumor macrolide, functions as a novel topoisomerase II poison.

Xie CY, Zhu H, Lin LP, Miao ZH, Geng MY, Cai YJ, Chen Y, Zhao HJ, Luo HB, Zhang XW, Fan LM, Shen YM, Ding J. Xie CY, et al. Mol Cancer Ther. 2007 Nov;6(11):3059-70. doi: 10.1158/1535-7163.MCT-07-0014. Mol Cancer Ther. 2007. PMID: 18025289

5

HH-GV-678, a novel selective inhibitor of Bcr-Abl, outperforms imatinib and effectively overrides imatinib resistance.

Luo H, Quan H, Xie C, Xu Y, Fu L, Lou L. Luo H, et al. Among authors: xie c. Leukemia. 2010 Oct;24(10):1807-9. doi: 10.1038/leu.2010.169. Epub 2010 Aug 12. Leukemia. 2010. PMID: 20703259 No abstract available.

6

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo.

Tian S, Quan H, Xie C, Guo H, Lü F, Xu Y, Li J, Lou L. Tian S, et al. Among authors: xie c. Cancer Sci. 2011 Jul;102(7):1374-80. doi: 10.1111/j.1349-7006.2011.01939.x. Epub 2011 May 9. Cancer Sci. 2011. PMID: 21443688 Free PMC article. Clinical Trial.

7

A novel water-soluble heptaplatin analogue with improved antitumor activity and reduced toxicity.

Liu W, Chen X, Ye Q, Xu Y, Xie C, Xie M, Chang Q, Lou L. Liu W, et al. Among authors: xie c, xie m. Inorg Chem. 2011 Jun 20;50(12):5324-6. doi: 10.1021/ic200436u. Epub 2011 May 20. Inorg Chem. 2011. PMID: 21598993

8

A novel and simple hollow-fiber assay for in vivo evaluation of nonpeptidyl thrombopoietin receptor agonists.

Xie CY, Xu YP, Zhao HB, Lou LG. Xie CY, et al. Exp Hematol. 2012 May;40(5):386-92. doi: 10.1016/j.exphem.2012.01.010. Epub 2012 Jan 21. Exp Hematol. 2012. PMID: 22269115 Free article.

9

Synthesis and cytotoxicity of diam(m)ineplatinum(II) complexes with 2,2-bis(hydroxymethyl)malonate as the leaving group.

Xing Y, Lou L, Chen X, Ye Q, Xu Y, Xie C, Jiang J, Liu W. Xing Y, et al. Among authors: xie c. Bioorg Med Chem Lett. 2012 Mar 15;22(6):2239-41. doi: 10.1016/j.bmcl.2012.01.091. Epub 2012 Feb 2. Bioorg Med Chem Lett. 2012. PMID: 22357340

10

Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.

Xie CY, Xu YP, Jin W, Lou LG. Xie CY, et al. Anticancer Drugs. 2012 Aug;23(7):698-705. doi: 10.1097/CAD.0b013e328352cc10. Anticancer Drugs. 2012. PMID: 22441567

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,367 results

Search Page

Filters